J-Pharma Co (TSE:520A) Probability of Financial Distress (%)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:520A J-Pharma Co Ltd TSE:520A
9 GF Score
Price 円290.00
View Full Analysis

What is J-Pharma Co Probability of Financial Distress (%)?

J-Pharma Co does not have enough data to calculate Probability of Financial Distress (%).

J-Pharma Co  (TSE:520A) Probability of Financial Distress (%) Explanation

Like the Altman Z-Score, the PFD measures a company's bankruptcy risk in the upcoming year. However, the main drawback of the Z-score is it does not apply to banks and insurance companies. According to Investopedia, the concept of "working capital" does not apply to banks and insurance companies, as financial institutions do not have typical current assets or current liabilities like inventories or accounts payable.

J-Pharma Co Probability of Financial Distress (%) Related Terms

J-Pharma Co Probability of Financial Distress (%) Historical Data

* Premium members only.

The historical data trend for J-Pharma Co's Probability of Financial Distress (%) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

J-Pharma Co Probability of Financial Distress (%) Chart

J-Pharma Co Annual Data
Trend Mar24 Mar25
Probability of Financial Distress (%)
0.00 0.00

J-Pharma Co Quarterly Data
Mar24 Mar25 Dec25
Probability of Financial Distress (%) 0.00 0.00 0.00

TSE:520A vs VRTX, REGN, ALNY: Probability of Financial Distress (%) Comparison

For the Biotechnology subindustry, J-Pharma Co's Probability of Financial Distress (%), along with its competitors' market caps and Probability of Financial Distress (%) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

J-Pharma Co Probability of Financial Distress (%) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, J-Pharma Co's Probability of Financial Distress (%) distribution charts can be found below:

* The bar in red indicates where J-Pharma Co's Probability of Financial Distress (%) falls into.


TSE:520A
9GF Score
J-Pharma Co Ltd TSE:520A
Probability of Financial Distress (%) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

J-Pharma Co Business Description

Address 1-10-11, HamamatsuCho, 8th floor, Minato-Ku, Tokyo, JPN, 105-0013
J-Pharma Co Ltd is engaged in the Drug discovery and development targeting SLC transporters. It is focused on a single segment of the drug discovery business, focusing on R&D and clinical development. The company's two compounds in clinical development are Nanbran Latte (JPH203) and JPH034.
9GF Score

Get the complete analysis for TSE:520A

Probability of Financial Distress (%) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円290.00
Price